We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.

For more information visit our privacy policy.

Termination 15 Sample Clauses

Termination 15Ukončení platnosti Quintiles and/or Sponsor may terminate this Agreement for any reason effective immediately upon written notice. Quintiles a/nebo Zadavatel jsou oprávněni ukončit platnost této Smlouvy z jakéhokoli důvodu s okamžitou účinností neprodleně na základě doručení písemného oznámení. The Site may terminate upon written notice of no less then sixty (60) days to the other Party if circumstances beyond the Site’s reasonable control prevent completion of the Study, or if it reasonably determines that it is unsafe to continue the Study. Upon receipt of notice of termination, the Site shall immediately cease any subject recruitment, follow the specified termination procedures, ensure that any required subject follow-up procedures are completed, and make all reasonable efforts to minimize further costs, and Quintiles shall make a final payment on a completed visit per subject basis visits or milestones properly performed pursuant to this Agreement in the amounts specified in Attachment A; If a material breach of this Agreement appears to have occurred and termination may be required, then, except to the extent that Study Subject safety may be jeopardized, Quintiles and/or Sponsor may suspend performance of all or part of this Agreement, including, but not limited to, subject enrollment. Místo provádění klinického hodnocení je oprávněno ukončit platnost této Smlouvy písemným oznámením zaslaným druhé smluvní Straně nejméně šedesát (60) dnů předem v případě, že okolnosti, jež jsou svojí povahou mimo možnost ovlivnění ze strany Místa provádění klinického hodnocení, zabrání dokončení Studie, nebo v případě, že Místo provádění klinického hodnocení důvodně usoudí, že pokračování ve Studii není bezpečné. V návaznosti na doručení oznámení o ukončení platnosti Místo provádění klinického hodnocení neprodleně ukončí jakýkoli nábor subjektů, bude jednat v souladu s definovanými postupy pro ukončení, zajistí, že ve vztahu k subjektům Studie budou dokončeny jakékoli procesy kontrolní povahy, a vyvinou nezbytné úsilí za účelem limitace jakýchkoli dalších nákladů, přičemž Quintiles provede závěrečnou úhradu na základě uskutečněných návštěv jednotlivých subjektů za návštěvy a milníky, jež byly řádně provedeny na základě a v souladu s touto Smlouvou, a to ve výši částek definovaných v Příloze A.V případě, že dojde ke vzniku domnění, že došlo k podstatnému porušení této Smlouvy a může tak dojít k ukončení platnosti této Smlouvy, pak s výjimkou a x xxxxxxx, x xxxxx xxxx xx...
Termination 15. 2 Ukončení platnosti IQVIA and/or Sponsor may terminate this Agreement for any reason effective immediately upon written notice. IQVIA a/nebo Zadavatel jsou oprávněni ukončit platnost této Smlouvy z jakéhokoli důvodu s okamžitou účinností neprodleně na základě doručení písemného oznámení. The Site may terminate upon written notice if circumstances beyond the Site’s reasonable control prevent completion of the Study, or if it reasonably determines that it is unsafe to continue the Study. Upon receipt of notice of termination, the Site shall immediately cease any subject recruitment, follow the specified termination procedures, ensure that any required subject follow-up procedures are completed, and make all reasonable efforts to minimize further costs, and IQVIA shall make a final payment for visits or milestones properly performed pursuant to this Agreement in the amounts specified in Attachment A; Payments will be in each case reduced by ten (10 %) percent. This reduced amount shall represent a value of any/all activities related to close-out of the database, and will be made upon the final acceptance by Místo provádění klinického hodnocení je oprávněno ukončit platnost této Smlouvy písemným oznámením v případě, že okolnosti, jež jsou svojí povahou mimo možnost ovlivnění ze strany Místa provádění klinického hodnocení, zabrání dokončení Studie, nebo v případě, že Místo provádění klinického hodnocení důvodně usoudí, že pokračování ve Studii není bezpečné. V návaznosti na doručení oznámení o ukončení platnosti Místo provádění klinického hodnocení neprodleně ukončí jakýkoli nábor subjektů, bude jednat v souladu s definovanými postupy pro ukončení, zajistí, že ve vztahu k subjektům Studie budou dokončeny jakékoli procesy kontrolní povahy, a vyvinou nezbytné úsilí za účelem limitace jakýchkoli dalších nákladů, přičemž IQVIA provede Sponsor of all CRF pages and all data clarifications issued and satisfaction of all other applicable conditions set forth herein. If a material breach of this Agreement appears to have occurred and termination may be required, then, except to the extent that Study Subject safety may be jeopardized, IQVIA and/or Sponsor may suspend performance of all or part of this Agreement, including, but not limited to, subject enrollment. závěrečnou úhradu za návštěvy a milníky, jež byly řádně provedeny na základě a v souladu s touto Smlouvou, a to ve výši částek definovaných v Příloze A; avšak za podmínky, že Platby budou v každém případě snížen...
Termination 15. 2.1 Sponsor may terminate this Agreement for any reason effective immediately upon written notice.
Termination 15Section 4.1 Early Termination of Agreement; Breach of Agreement 15 Section 4.2 Early Termination Notice 16 Section 4.3 Payment Upon Early Termination 17 ARTICLE V. SUBORDINATION AND LATE PAYMENTS 17 Section 5.1 Subordination 17 Section 5.2 Late Payments by the Corporation 18 ARTICLE VI. TAX MATTERS; CONSISTENCY; COOPERATION 18 Section 6.1 Participation in the Corporation’s and the LLC’s Tax Matters 18 Section 6.2 Consistency 18 Section 6.3 Cooperation 18 ARTICLE VII. MISCELLANEOUS 18 Section 7.1 Notices 18 Section 7.2 Counterparts 19 Section 7.3 Entire Agreement; No Third Party Beneficiaries 19 Section 7.4 Governing Law 20 Section 7.5 Severability 20 Section 7.6 Assignments; Amendments; Successors; No Waiver 20 Section 7.7 Titles and Subtitles 21 Section 7.8 Resolution of Disputes 21 Section 7.9 Reconciliation 22 Section 7.10 Withholding 22 Section 7.11 Admission of the Corporation into a Consolidated Group; Transfers of Corporate Assets 23 Section 7.12 Confidentiality 23 Section 7.13 Change in Law 24 Section 7.14 Interest Rate Limitation 24 Section 7.15 Independent Nature of Rights and Obligations 24 Section 7.16 LLC Agreement 25 Section 7.17 Rules of Construction 25 Exhibit AForm of Joinder Agreement This TAX RECEIVABLE AGREEMENT, dated as of [ ] [ ], 2018, is hereby entered into by and among i3 Verticals, Inc., a Delaware corporation (the “Corporation”), i3 Verticals, LLC, a Delaware limited liability company (the “LLC”), and each of the Members from time to time party hereto. Capitalized terms used but not otherwise defined herein have the respective meanings set forth in Section 1.1.
Termination 15The Minister may at any time prior to the expiry of the Term, immediately terminate this PLA, without cause, upon written notice to the Manufacturer.
Termination 15. 1 If you wish to terminate this Agreement for any reason you must give the Company notice in writing. Subject to the provisions of clause 15.3(iii), the minimum Notice Period to be given by you is specified in the Schedule. 15.2 The Company may terminate your employment under this Agreement at any time: LUXFER HOLDINGS PLC Xxxxxxxxx Xxxxxxx, 0 Xxxxxxxxx Xxxx, Xxxxxxx, X00 0XX (i) Except in circumstance involving a Change of Control, which will entitle you to payment in accordance with clause 15.11, if the Company terminates this Agreement for any reason otherwise than pursuant to clause 15.2(ii), the Company will pay you, in lieu of the Notice Period to which you are entitled under the Schedule, a sum equal to your annual basic salary and Target Bonus Opportunity (together the “XXXXX”). In addition, all outstanding and unvested time-based awards will be vested immediately and transferred to you in a timely manner consistent with Government regulations. Performance based awards will be dealt with in line with the Company’s Remuneration Policy and LTiP rules. Your employment with the Company will end at the date of payment of the XXXXX and, following satisfaction of the terms of this clause 15.3(i), the Company will have no further liability under this Agreement. LUXFER HOLDINGS PLC Xxxxxxxxx Xxxxxxx, 0 Xxxxxxxxx Xxxx, Xxxxxxx, X00 0XX
Termination 15. 1If Seller defaults in any of its obligations under the Contract, or becomes insolvent, or has a receiver appointed of its business, or is compulsorily or voluntarily wound up, or if Accell in good faith believes that any of such events may occur, Accell shall be entitled at its discretion, and without prejudice to any other remedy, to suspend the performance of or terminate the Contract and in the event of termination to keep or take possession of any Products or of any items belonging to Accell and to enter any premises of Seller for that purpose. 15.2If Accell terminates the Contract, Seller shall return to Accell all payments made and if Accell rejects any Products or Services Seller shall return all payments made for the rejected Products or Services. Where upon termination Accell elects to keep or take any Products, it shall account to Seller for them at a proportion of their price or 13.3Accell 可将合同全部或部分转让,或将合同的一部分分包给任何个人、企业或公司。 第14条 保险 14.1卖方应始终自费向知名的保险公司就合同项下可保的风险进行充分的投保,包括但不限于一般责任、雇主责任、产品责任、财产损害和业务中断。经要求,卖方应提供由保险公司签署的保险凭 证。 第15条 合同终止 15.1如果卖方不履行其在合同项下的任何义务,或变得资不抵债,或其业务被指定接管人接管,或被强制或自愿清盘,或者如果 Accell 善意地认为任何该等事件可能发生,Accell 有权自行决定,在不影响任何其他救济的情况下中止履行或终止本合同,并在终止时保留或占有任何产品或属于 Accell 的任何物品,并为该等目的进入卖方的任何场地。 15.2 如果 Accell 终止合同,卖方应向 Accell退还已支付的所有款项,如果 Accell 拒收任何产品或服务,卖方应向 Accell 退还就拒收的产品或服务支付的所有款 项。如果终止后 Accell 选择保留或接收任何产品,Accell 应按照该等产品的价格或该等产品对 Accell 的价值(以较低者为准)向卖方支付相应比例的款项, 否则,在终止或拒收时,不应向卖方支 their value to Accell, whichever is less, but otherwise no compensation shall be payable to Seller on termination or rejection. 付任何赔偿。
Termination 15. 4 You shall not assign, sublicense or otherwise transfer 11.1 Either party may terminate this Agreement by giving 30 days Agreement or any of its rights or obligations whether in whole written notice to the other at any time. in part without the prior written consent of Mortgage Brain. 11.2 Either party may terminate this Agreement immediately upon 15.5 Neither party will be liable to the other for any failure or delay written notice to the other if the other: for the consequences of any failure or delay in performance 11.2.1 is in material breach of this Agreement and fails to remedy such this Agreement, excluding your obligation to pay the Fees, if it breach within 30 days of notice being served by the other party; due to any event beyond the reasonable control of a party to 11.2.2 becomes the subject of a petition in bankruptcy, whether Agreement including, without limitation, acts of God, voluntary or involuntary, which if involuntary is not dismissed industrial disputes, protests, fire, flood, xxxxx, xxxxxxx, within 60 days, or becomes insolvent, or ceases to do business in an act of terrorism and national emergencies. If such delay the normal course or any other similar situation arises; or failure continues for at least 30 days, the party not subject to 11.2.3 is prevented from performing its obligations under this Agreement an event shall be entitled to terminate this Agreement for a period of 30 consecutive days or more due to a force accordance with clause 11.2.3. The party subject to such majeure event described in clause 15.5. shall, as soon as practicable, give notice of the event to the 11.3 Mortgage Brain shall have the right to terminate this Agreement party, such notice to include a reasonable forecast of the if you are in breach of clause 8.6. of the event. 11.4 The clauses in this Agreement which expressly or impliedly have 15.6 No failure of either party to enforce its rights under effect after termination shall continue to be enforceable Agreement at any time for any period shall be construed as notwithstanding termination. waiver of such rights. 11.5 Any termination of this Agreement shall be without prejudice to 15.7 If any provision in this Agreement is found or held to be invalid the accrued rights and remedies of the parties. unenforceable, then the meaning of such provision shall
Termination 15. 2 Ukončení platnosti IQVIA and/or Sponsor may terminate this Agreement for any reason effective immediately upon written notice. IQVIA a/nebo Zadavatel jsou oprávněni ukončit platnost této Smlouvy z jakéhokoli důvodu s okamžitou účinností neprodleně na základě doručení písemného oznámení. The Site may terminate upon written notice if at any time in the Investigator’s professional judgment, a material adverse safety concern Místo provádění klinického hodnocení je oprávněno ukončit platnost této Smlouvy písemným oznámením pokud kdykoli, na for the Study Subjects makes continued testing inadvisable. The Institution may terminate this Agreement in writing if, as a result of a hindrance beyond the control of the Institution, the Institution is rendered long-term incapable to complete the Study, without its main operation being hindered, which is the provision of healthcare services. The notice period shall be 30 days and shall start on the day following the day of its receipt by Sponsor, IQVIA and the the Investigator. Upon notice of termination or upon notice of suspension of the Study or this Agreement, Site shall immediately cease enrollment of subjects into the Study and, at the election of IQVIA shall (a) either (i) terminate the Agreement with respect to the enrolled subjects in an orderly and prompt manner and pursuant to consultation with IQVIA and Sponsor, including any required follow-up treatment with previously enrolled subjects, or (ii) transfer the enrolled subjects to another clinical site in accordance with IQVIA’ instructions. Sponsor or its designee shall have the right to assume full control of the terminated Study and Site shall turn over all Study Documentation and materials in its possession associated with the Study, as expeditiously as possible, and shall provide such other assistance as is necessary to ensure a smooth and orderly transition of the Study without any disruption of the Protocol and (b) Site shall make all reasonable efforts to minimize further costs, and IQVIA shall make a final payment for visits or milestones properly performed pursuant to this Agreement in the amounts specified in Attachment A. základě odborného úsudku Hlavního zkoušejícího, závažné obavy o bezpečnost Subjektů studie způsobí, že další testování bude nežádoucí. Zdravotnické zařízení je oprávněno ukončit tuto smlouvu písemnou výpovědí, jestliže v důsledku vzniku překážky, jež nastala nezávisle na jeho vůli, nebude Zdravotnické zařízení dlouhodobě schopno ...